Literature DB >> 20063011

The impact of smoking and polymorphic enzymes of xenobiotic metabolism on the stage of bladder tumors: a generalized ordered logistic regression analysis.

Sami Khedhiri1, Nejla Stambouli, Slah Ouerhani, Kamel Rouissi, Raja Marrakchi, Amel B Gaaied, M B Slama.   

Abstract

Cigarette smoking is the predominant risk factor for bladder cancer in males and females. The tobacco carcinogens are metabolized by various xenobiotic metabolizing enzymes such as N-acetyltransferases (NAT) and glutathione S-transferases (GST). Polymorphisms in NAT and GST genes alter the ability of these enzymes to metabolize carcinogens. In this paper, we conduct a statistical analysis based on logistic regressions to assess the impact of smoking and metabolizing enzyme genotypes on the risk to develop bladder cancer using a case-control study from Tunisia. We also use the generalized ordered logistic model to investigate whether these factors do have an impact on the progression of bladder tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063011     DOI: 10.1007/s00432-009-0758-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

Review 1.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

2.  A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms.

Authors:  M Arand; R Mühlbauer; J Hengstler; E Jäger; J Fuchs; L Winkler; F Oesch
Journal:  Anal Biochem       Date:  1996-04-05       Impact factor: 3.365

Review 3.  Glutathione transferases.

Authors:  John D Hayes; Jack U Flanagan; Ian R Jowsey
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

4.  GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer.

Authors:  S Z Abdel-Rahman; W A Anwar; W E Abdel-Aal; H M Mostafa; W W Au
Journal:  Cancer Detect Prev       Date:  1998

5.  Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility.

Authors:  H J Lin; C Y Han; D A Bernstein; W Hsiao; B K Lin; S Hardy
Journal:  Carcinogenesis       Date:  1994-05       Impact factor: 4.944

6.  [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].

Authors:  Gang-yue Hao; Wei-dong Zhang; Yong-he Chen; Dao-xin Zhang; Yu-hai Zhang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2004-05

7.  Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.

Authors:  M C Yu; P L Skipper; K Taghizadeh; S R Tannenbaum; K K Chan; B E Henderson; R K Ross
Journal:  J Natl Cancer Inst       Date:  1994-05-04       Impact factor: 13.506

8.  Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.

Authors:  A F Badawi; A Hirvonen; D A Bell; N P Lang; F F Kadlubar
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

Review 9.  N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.

Authors:  D W Hein
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

10.  Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells.

Authors:  M T Kloth; R L Gee; E M Messing; S Swaminathan
Journal:  Carcinogenesis       Date:  1994-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.